Stock Analysis on Net

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Medtronic PLC, consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

Microsoft Excel
Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021 Apr 30, 2021 Jan 29, 2021 Oct 30, 2020 Jul 31, 2020 Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018 Apr 27, 2018 Jan 26, 2018 Oct 27, 2017 Jul 28, 2017
Current debt obligations 1,029 1,339 519 20 5,918 5,864 5,729 3,742 865 16 6 11 3,821 4,041 5,823 2,776 844 875 1,458 838 1,356 1,343 1,545 2,058 2,902 3,131 8,058
Accounts payable 1,992 2,174 2,239 2,662 2,209 2,198 2,180 2,276 1,985 1,917 1,864 2,106 1,816 1,902 1,720 1,996 1,945 1,965 1,906 1,953 1,706 1,742 1,789 1,628 1,809 1,718 1,759
Accrued compensation 2,174 1,758 1,695 1,949 2,007 1,721 1,773 2,121 2,152 1,934 1,901 2,482 2,495 2,133 1,815 2,099 1,909 1,773 1,507 2,189 1,796 1,663 1,371 1,988 1,645 1,502 1,304
Accrued income taxes 1,109 1,088 1,013 840 657 651 549 704 383 467 341 435 403 406 390 502 457 442 500 567 648 536 784 979 925 872 717
Other accrued expenses 3,489 3,300 3,581 3,580 3,631 4,031 3,818 3,551 3,542 3,469 3,652 3,475 3,999 3,589 3,338 2,993 3,580 3,115 3,147 2,925 3,347 3,179 3,623 3,431 3,652 3,273 3,251
Current liabilities held for sale 59
Current liabilities 9,793 9,659 9,047 9,051 14,422 14,465 14,049 12,394 8,927 7,803 7,764 8,509 12,534 12,071 13,086 10,366 8,735 8,170 8,518 8,472 8,853 8,463 9,112 10,084 10,933 10,496 15,148
Long-term debt 24,153 23,741 24,463 24,344 22,210 20,753 17,481 20,372 24,290 25,607 25,958 26,378 26,502 25,967 22,867 22,021 24,732 24,752 24,804 24,486 23,674 23,673 23,678 23,699 25,918 25,941 25,953
Accrued compensation and retirement benefits 1,049 1,020 1,092 1,093 1,103 1,048 1,102 1,113 1,369 1,505 1,521 1,557 2,042 2,024 1,962 1,910 1,598 1,573 1,640 1,651 1,313 1,301 1,412 1,425 1,524 1,475 1,663
Accrued income taxes 1,821 1,777 2,407 2,360 2,305 2,614 2,102 2,087 2,115 2,110 2,262 2,251 2,263 2,569 2,719 2,682 2,738 2,705 2,873 2,838 2,874 2,950 3,042 3,051 4,758 2,194 2,170
Deferred tax liabilities 615 686 687 708 747 871 899 884 968 1,024 1,054 1,028 1,232 1,251 1,231 1,174 1,282 1,376 1,346 1,278 1,356 1,325 1,347 1,423 1,363 1,841 2,610
Other liabilities 1,409 1,557 1,714 1,727 1,729 1,433 1,438 1,410 1,422 1,547 1,578 1,758 1,769 1,688 1,598 1,664 1,784 1,758 1,590 757 719 724 801 889 964 933 1,026
Noncurrent liabilities held for sale 893
Noncurrent liabilities 29,047 28,781 30,363 30,232 28,094 26,719 23,022 25,866 30,164 31,793 32,373 32,972 33,808 33,499 30,377 29,451 32,134 32,164 32,253 31,010 29,936 29,973 30,280 30,487 34,527 32,384 34,315
Total liabilities 38,840 38,440 39,410 39,283 42,516 41,184 37,071 38,260 39,091 39,596 40,137 41,481 46,342 45,570 43,463 39,817 40,869 40,334 40,771 39,482 38,789 38,436 39,392 40,571 45,460 42,880 49,463
Ordinary shares, par value $0.0001
Additional paid-in capital 24,589 24,580 24,587 24,590 24,513 24,442 24,335 24,566 25,814 26,059 26,184 26,319 26,665 26,481 26,261 26,165 26,144 26,171 26,470 26,532 26,518 27,048 27,817 28,127 28,190 28,091 28,553
Retained earnings 30,661 30,257 30,265 30,392 30,117 29,799 30,276 30,250 29,607 28,974 28,511 28,594 28,015 27,526 27,817 28,132 28,210 27,018 26,377 26,270 25,769 25,171 24,730 24,379 23,426 25,438 24,043
Accumulated other comprehensive loss (3,458) (3,377) (3,674) (3,499) (3,189) (2,361) (1,939) (2,265) (2,879) (3,042) (3,209) (3,485) (3,922) (3,843) (3,782) (3,560) (2,546) (2,611) (2,484) (2,711) (2,458) (2,612) (2,323) (1,786) (1,382) (2,060) (1,924)
Shareholders’ equity 51,792 51,460 51,178 51,483 51,441 51,880 52,672 52,551 52,542 51,991 51,486 51,428 50,758 50,164 50,296 50,737 51,808 50,578 50,363 50,091 49,829 49,607 50,224 50,720 50,234 51,469 50,672
Noncontrolling interests 204 187 188 182 177 177 171 171 171 168 178 174 170 152 147 135 145 141 134 121 112 107 105 102 106 109 115
Total equity 51,996 51,647 51,366 51,665 51,618 52,057 52,843 52,722 52,713 52,159 51,664 51,602 50,928 50,316 50,443 50,872 51,953 50,719 50,497 50,212 49,941 49,714 50,329 50,822 50,340 51,578 50,787
Total liabilities and equity 90,836 90,087 90,776 90,948 94,134 93,241 89,914 90,982 91,804 91,755 91,801 93,083 97,270 95,886 93,906 90,689 92,822 91,053 91,268 89,694 88,730 88,150 89,721 91,393 95,800 94,458 100,250

Based on: 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31), 10-K (reporting date: 2020-04-24), 10-Q (reporting date: 2020-01-24), 10-Q (reporting date: 2019-10-25), 10-Q (reporting date: 2019-07-26), 10-K (reporting date: 2019-04-26), 10-Q (reporting date: 2019-01-25), 10-Q (reporting date: 2018-10-26), 10-Q (reporting date: 2018-07-27), 10-K (reporting date: 2018-04-27), 10-Q (reporting date: 2018-01-26), 10-Q (reporting date: 2017-10-27), 10-Q (reporting date: 2017-07-28).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Medtronic PLC current liabilities increased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.
Noncurrent liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Medtronic PLC noncurrent liabilities decreased from Q1 2024 to Q2 2024 but then slightly increased from Q2 2024 to Q3 2024.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Medtronic PLC total liabilities decreased from Q1 2024 to Q2 2024 but then slightly increased from Q2 2024 to Q3 2024.
Shareholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Medtronic PLC shareholders’ equity increased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.